Literature DB >> 4029024

Potential role of temocillin in the treatment of biliary sepsis.

M Uwaydah, S Vartivarian, H Harakeh, A Awdeh, F Najjar.   

Abstract

Temocillin concentrations were determined in the gallbladder bile and/or common bile duct bile obtained intraoperatively from 20 patients, and in the T-tube bile of 5 postoperative patients. Blood samples were also obtained for determining the concomitant serum antibiotic concentrations. In 6 patients with cholelithiasis, but without common bile duct obstruction or acute infection, the mean temocillin concentrations were 890 mg/L in gallbladder bile and 1030 mg/L in common bile duct bile. In the group of 6 patients with common bile duct obstruction, the antibiotic concentrations ranged between 5.6 and 88 mg/L (mean 38.8 mg/L) in gallbladder bile and between 'undetectable' and 700 mg/L in common bile duct bile. In patients with biliary sepsis, a further reduction in temocillin bile concentrations was observed, and postoperatively, the T-tube bile temocillin concentrations were in the range of 21 to 460 mg/L (mean 130 mg/L). The clinical efficacy of temocillin in the 7 patients with acute cholecystitis was judged to be satisfactory. Our results suggest that temocillin may be considered as a potentially useful antibiotic in the treatment of patients with biliary tract sepsis caused by susceptible organisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029024     DOI: 10.2165/00003495-198500295-00040

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  6 in total

1.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

2.  Antibiotics in bile.

Authors:  M Thomas
Journal:  J Antimicrob Chemother       Date:  1983-11       Impact factor: 5.790

3.  Temocillin bile levels.

Authors:  M Uwaydah; F Najjar; S Vartivarian; H Harakeh
Journal:  J Antimicrob Chemother       Date:  1984-08       Impact factor: 5.790

4.  Cefamandole bile levels in patients with hepatobiliary disease.

Authors:  M Uwaydah; H Kantarjian; M Osseiran; F Bal'a
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

5.  Ampicillin levels in human bile in the presence of biliary tract disease.

Authors:  P R Mortimer; D B Mackie; S Haynes
Journal:  Br Med J       Date:  1969-07-12

6.  The influence of biliary disease on the excretion of cefazolin in human bile.

Authors:  A R McLeish; C J Strachan; S J Powis; R Wise; P G Bevan
Journal:  Surgery       Date:  1977-04       Impact factor: 3.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.